Sec Form 13G Filing - Northpond Ventures LP filing for Candel Therapeutics, Inc. (CADL) - 2025-02-14

Insider filing report for Changes in Beneficial Ownership

  • Schedule 13G & 13D forms are used to report a party's ownership of stock which exceeds 5% of a company's total stock issue.
  • Schedule 13G is a shorter version of Schedule 13D with fewer reporting requirements.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Checkbox not checked   Rule 13d-1(b)
Checkbox not checked   Rule 13d-1(c)
Checkbox checked   Rule 13d-1(d)






SCHEDULE 13G




SCHEDULE 13G




SCHEDULE 13G




SCHEDULE 13G




SCHEDULE 13G




SCHEDULE 13G
< td width="100%" colspan="2" class="tableClassNoBorder">


 
Northpond Ventures, LP
 
Signature:/s/ Patrick Smerkers
Name/Title:By: Northpond Ventures GP, LLC, its General Partner, By Patrick Smerkers, Authorized Signatory
Date:02/14/2025
 
Northpond Ventures GP, LLC
 
Signature:/s/ Patrick Smerkers
Name/Title:By Patrick Smerkers, Authorized Signatory
Date:02/14/2025
 
Northpond Ventures II, LP
 
Signature:/s/ Patrick Smerkers
Name/Title:By: Northpond Ventures II GP, LLC, its General Partner, By Patrick Smerkers, Authorized Signatory
Date:02/14/2025
 
Northpond Ventures II GP, LLC
 
Signature:/s/ Patrick Smerkers
Name/Title:By Patrick Smerkers, Authorized Signatory
Date:02/14/2025
 
Michael P. Rubin
 
Signature:/s/ Michael P. Rubin
Name/Title:Michael P. Rubin, Self
Date:02/14/2025
primary_doc.xml